KOS is the company at the head of a prime Italian healthcare group operating in the care-home sector. The mission of the group is to offer healthcare and long-term care in a professional, welcoming and humane way, valuing talent and promoting the contribution of individuals. The facilities managed by KOS place patients at the centre of their activity and give top priority to their needs and requirements. Established by CIR in 2002 and with an interest held by AXA Private Equity, the company is active in three business areas: 

  • Nursing homes (RSAs):  KOS is the top private Italian provider in terms of number of beds under management in care homes for the non-self sufficient elderly, where it operates under the brand  Anni Azzurri.
  • Rehabilitation: KOS is the fourth private Italian operator in terms of beds under management in functional psychiatric rehabilitation units, where it operates under the brands  Santo Stefano (functional rehabilitation) and Redancia (psychiatric rehabilitation).
  • Hospital facilities: providing advanced and complex hi-tech medical services (diagnostic imagining, nuclear medicine and radio therapy) as an external service provider for the Naional Health Service, under the Medipass brand. In this business area, the group also manages the  Fratelli Montecchi Hospital in Suzzara (Mantua).

KOS manages 63 facilities in central and northern Italy, for a total of more than 5,800 beds, plus over 1,000 under construction. In 2011, KOS posted  consolidated revenues of 349.6 million euro, EBITDA of approximately 52.2 million euro and a net income of 8.9 million euro. The breakdown in percentage terms of 2011 revenues by business area is as follows: RSAs 40%, Rehabilitation 43%, Hospitals facilities 17%. The CEO of KOS is Giuseppe Vailati Venturi.

KOS: geographic presence in Italy

KOS: geographic presence in Italy

KOS: sales growth

KOS: sales growth

KOS : 2011 Revenues by type of business

KOS : Revenues by type of business

KOS: shareholder structure

KOS

SHAREHOLDERS

  • CIR (51.3%)
  • AXA Private Equity (46.7%)
  • Management & others  (2.0%)